Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series B
Biotech
Ethyreal Bio raises $101M, joining biotechs gunning for Tepezza
Backed by investors including Atlas Venture and Medicxi Ventures, Ethyreal has quietly advanced an anti-TSHR antibody to the cusp of the clinic.
Nick Paul Taylor
Jun 10, 2026 9:35am
Crossbow hits $77M series B round to bankroll quiver of T-Bolts
Mar 18, 2026 10:50am
Sanofi backs Altesa's $75M series B to bankroll rhinovirus study
Feb 19, 2026 7:00am
J&J, Google venture arms line up to back EpiBiologics' series B
Jan 8, 2026 9:05am
Series B round of $125M will fund Diagonal's move into clinic
Jan 8, 2026 6:30am
Fierce Biotech Fundraising Tracker: Syneron, Atavistik & more
Dec 19, 2025 2:00pm
